Article citationsMore>>

Neuen, B.L., Heerspink, H.J.L., Vart, P., Claggett, B.L., Fletcher, R.A., Arnott, C., et al. (2024) Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment with SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared with Conventional Care in Patients with Type 2 Diabetes and Albuminuria. Circulation, 149, 450-462.
https://doi.org/10.1161/circulationaha.123.067584

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top